Delivery Order SPE2DB22D1106-SPE2DB24FFLP6
Award Date
9/7/24
Potential Completion Date
9/9/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,124.88, is for the delivery of 4564766828 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of KETOROLAC 30 MG/ML VIAL. The $2,624.72 firm-fixed-price contract has a period of performance through May 29, 2024 and is not set aside. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vial, a pharmaceutical product. The contract has a ceiling value of $1,588.62 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, with a ceiling value of $25,342.53 and a performance period through June 27, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award, valued at $2,249.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. There was no set-aside designation for this award. Amerisourcebergen holds a...
This federal contract award, with a ceiling value of $1,327.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of KETOROLAC 30 MG/ML VIALML, a generic pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a medication, with a ceiling value of $1,009.83 and a performance period ending on June 12, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a critical supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a prescription medication. The contract has a ceiling value of $3,325.68 and is a Firm Fixed Price contract. The period of performance extends to August 29, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded numerous federal contracts and...
This is a $1,874.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4565597417 - Ketorolac 30 MG/ML Vial. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support...